跳至主要内容
临床试验/IRCT2014112019554N2
IRCT2014112019554N2已完成2 期

Treatment effects of familact Probiotic in Non Alcoholic Fatty Liver Disease(NAFLD)

Zanjan University of Medical Sciences, Deputy of Research and Technology, Research Management0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • patients with NAFLD on ultrasonography; ALT more than 1.5 to 5 times the normal range; BMI between 25 to 29.9
  • Exclusion criteria: alcoholic hepatitis; systemic or metabolic or inflammatory disease such as diabetes; viral hepatitis; autoimmune hepatitis; secondary fatty liver disease such as drug induced fatty liver disease

排除标准

  • 未提供

研究者

发起方
Zanjan University of Medical Sciences, Deputy of Research and Technology, Research Management

相似试验